Delivery of Drugs for Medical Use (Deproteinized Hemoderivat of Blood of Calves)

RussiaTenders notice for Delivery of Drugs for Medical Use (Deproteinized Hemoderivat of Blood of Calves). The reference ID of the tender is 118561217 and it is closing on 13 May 2025.

100% Secure Payments

Tender Details

  • Country: Russia
  • Summary: Delivery of Drugs for Medical Use (Deproteinized Hemoderivat of Blood of Calves)
  • RUT Ref No: 118561217
  • Deadline: 13 May 2025
  • Competition: ICB
  • Financier: Self Financed
  • Purchaser Ownership: Public
  • Tender Value: 600000.00
  • Notice Type: Tender
  • Document Ref. No.: 0318300353425000019
  • Purchaser's Detail :
  • Purchaser : STATE BUDGETARY INSTITUTION OF HEALTH "CITY POLYCLINIC NO. 2 OF THE CITY OF NOVOROSSIYSK" OF THE MINISTRY OF HEALTH OF THE KRASNODAR TERRITORY
    353901, Krasnodar Territory, Novorossiysk, st. Proletarskaya, D. 7
    F.I.O:- Lazareva N.V.
    Contact phone number:- 8-8617-600066
    fax:- information is absent
    Email :gorodskay_polik2@mail.ru

  • Description :
  • Delivery of drugs for medical use (deproteinized hemoderivat of blood of calves)
  • Documents :
  •  Tender Notice

If you are registered member, kindly login to view full details of this tender notice:

CLICK HERE TO LOGIN
RussiaTenders Features

RussiaTenders Features

Fresh and verified Tenders from Russia. Find, search and filter Tenders/Call for bids/RFIs/RFPs/RFQs/Auctions published by the government, public sector undertakings (PSUs) and private entities.

  • 1,000+ Tenders
  • Verified Tenders Only
  • Accurate Tender Information
  • New Tenders Every Day
  • Consultants for RFI/RFP/RFQ
  • Search, sort, and filter Tenders
  • Customer Support
  • Publish your Tenders
  • Consulting Services
  • Export data to Excel or CRM

Get A Call From Tender Experts

Fill out the form below and you will receive a call from us within 24 hours.

Thank You for Contacting ZimbabweTenders !!
Email Id is already exist !!
Invalid Captcha !

Get FREE SAMPLE TENDERS from Russia in your email inbox.

  Chat with us